Acorah Software Products - Accounts Production 16.5.460 false true true 31 May 2024 1 December 2022 false 1 June 2024 31 May 2025 31 May 2025 09870341 Mr Ian Wilders iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09870341 2024-05-31 09870341 2025-05-31 09870341 2024-06-01 2025-05-31 09870341 frs-core:SharePremium 2025-05-31 09870341 frs-core:ShareCapital 2025-05-31 09870341 frs-core:RetainedEarningsAccumulatedLosses 2025-05-31 09870341 frs-bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 09870341 frs-bus:FilletedAccounts 2024-06-01 2025-05-31 09870341 frs-bus:SmallEntities 2024-06-01 2025-05-31 09870341 frs-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 09870341 frs-bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 09870341 frs-bus:Director1 2024-06-01 2025-05-31 09870341 frs-countries:EnglandWales 2024-06-01 2025-05-31 09870341 2022-11-30 09870341 2024-05-31 09870341 2022-12-01 2024-05-31 09870341 frs-core:CurrentFinancialInstruments 2024-05-31 09870341 frs-core:SharePremium 2024-05-31 09870341 frs-core:ShareCapital 2024-05-31 09870341 frs-core:RetainedEarningsAccumulatedLosses 2024-05-31
Registered number: 09870341
Beyond Labs Limited
Unaudited Financial Statements
For The Year Ended 31 May 2025
Joanna Burns t/a MyCloud-Accounts
Beyond Labs Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2—3

Page 1
Beyond Labs Limited
Balance Sheet
As At 31 May 2025
Balance Sheet
Registered number: 09870341

| 31 May 2025 | 31 May 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Debtors | 4 | 1,331 |  | 1,604 |
Cash at bank and in hand |  | 8,535 |  | 8,379 |
|  | 9,866 |  | 9,983 |
Creditors: Amounts Falling Due Within One Year | 5 | (7,982 ) |  | (7,507 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 1,884 |  | 2,476
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 1,884 |  | 2,476
NET ASSETS |  |  | 1,884 |  | 2,476
CAPITAL AND RESERVES
Called up share capital | 6 |  | 95,111 |  | 95,111
Share premium account |  |  | 285,266 |  | 285,266
Profit and Loss Account |  |  | (378,493 ) |  | (377,901 )
SHAREHOLDERS' FUNDS |  |  | 1,884 |  | 2,476

For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Ian Wilders Director
15/09/2025

The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Beyond Labs Limited
Notes to the Financial Statements
For The Year Ended 31 May 2025
Notes to the Financial Statements
1. General Information
Beyond Labs Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09870341 . The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors believe that the going concern basis is not appropriate as they have resolved to apply for the company to be struck off in accordance with section 1003 of the Companies Act 2006. These financial statements have therefore not been prepared on a going concern basis but on a break-up basis, reflecting the intention to settle all obligations
and distribute any remaining assets. The directors confirm that, at the date of approving these financial statements, the company is solvent and able to pay its debts as they fall due.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: 2)
- 2
4. Debtors

| 31 May 2025 |  | 31 May 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Other debtors | 1,331 |  | 1,604

5. Creditors: Amounts Falling Due Within One Year

| 31 May 2025 |  | 31 May 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | - |  | 1
Other creditors | 7,982 |  | 7,506
| 7,982 |  | 7,507

Page 2
Page 3
Beyond Labs Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 May 2025
6. Share Capital

| 31 May 2025 |  | 31 May 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 95,111 |  | 95,111

Page 3